Evidence map›Paper›PMID 42281837›Full record

ArticleChemical science2026

Reprogramming RiPP scaffolds through skeletal editing unlocks chemical space.

Hiroshige Ogawa, Longhui Yu, Shangzhao Li, Yuuya Nagata, Tsz Ki Chan, Yudai Matsuda, Jing Liu, Yong-Xin Li, Hugh Nakamura

Abstract read
In one paragraph

Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hiroshige OgawaThe Hong Kong University of Science and Technology Clear Water Bay Hong Kong SAR China hnakamura@ust.hk.
Longhui YuThe Hong Kong University of Science and Technology Clear Water Bay Hong Kong SAR China hnakamura@ust.hk.
Shangzhao LiThe Hong Kong University of Science and Technology Clear Water Bay Hong Kong SAR China hnakamura@ust.hk.
Yuuya NagataAutonomous Polymer Design and Discovery Group Research Center for Macromolecules and Biomaterials, National Institute for Materials Science (NIMS) 1-2-1 Sengen Tsukuba Ibaraki 305-0047 Japan.ORCID https://orcid.org/0000-0001-5926-5845
Tsz Ki ChanCity University of Hong Kong Tat Chee Avenue Kowloon Hong Kong SAR China.
Yudai MatsudaCity University of Hong Kong Tat Chee Avenue Kowloon Hong Kong SAR China.ORCID https://orcid.org/0000-0001-5650-4732
Jing LiuDepartment of Chemistry and The Swire Institute of Marine Science, The University of Hong Kong Hong Kong SAR China.
Yong-Xin LiDepartment of Chemistry and The Swire Institute of Marine Science, The University of Hong Kong Hong Kong SAR China.
Hugh NakamuraThe Hong Kong University of Science and Technology Clear Water Bay Hong Kong SAR China hnakamura@ust.hk.ORCID https://orcid.org/0000-0001-5475-7883

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we report (1) a scalable, systematic, and general synthetic approach for the supply of ribosomally synthesized and post-translationally modified peptides (RiPPs) bearing Tyr-Trp cross-linkages, and (2) the comprehensive expansion of novel chemical space through their skeletal diversification. In recent years, numerous biaryl-containing peptides have been discovered, and some of these RiPPs exhibit potent biological activities. However, despite the high metabolic stability and strong target protein binding generally attributed to biaryl RiPPs, their significant strain and rigidity have limited the availability of general synthetic methods. Here, we demonstrate the high versatility of modular synthetic strategies for the construction of RiPPs and achieve the synthesis of a variety of RiPPs containing Tyr-Trp cross-linkages. Furthermore, skeletal diversification

Identifiers

PMID42281837
PMCPMC13250620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.